|
|
 Previous Article | Table of Contents | Next Article 
High frequency of t(12;21) in childhood B-lineage acute lymphoblastic
leukemia
SP Romana, H Poirel, M Leconiat, MA Flexor, M Mauchauffe, P Jonveaux, EA Macintyre, R Berger and OA Bernard
U301 de l'Institut National de la Sante et de la Recherche Medicale, Paris,
France.
The recurrent t(12;21)(p12;q22) translocation fuses two genes, TEL and
AML1, that have previously been shown to be independently involved in
myeloid malignant proliferations. A search for rearrangement of the TEL
locus in the region known to be involved in t(12;21) was performed by
Southern blotting in a panel of hematopoietic malignancies. The presence of
a t(12;21) was confirmed by fluorescence in situ hybridization (FISH)
and/or reverse transcriptase (RT)-polymerase chain reaction (PCR). We
report that fusion of TEL to AML1 is specifically observed in at least 16%
of the childhood B-lineage acute lymphoblastic leukemia (ALL) investigated,
none of which had been previously identified as harboring t(12;21).
Volume 86,
Issue 11,
pp. 4263-4269,
12/01/1995
Copyright © 1995 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
E. DE BRAEKELEER, C. FEREC, and M. DE BRAEKELEER
RUNX1 Translocations in Malignant Hemopathies
Anticancer Res,
April 1, 2009;
29(4):
1031 - 1037.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Bakshi, S. K. Zaidi, S. Pande, M. Q. Hassan, D. W. Young, M. Montecino, J. B. Lian, A. J. van Wijnen, J. L. Stein, and G. S. Stein
The leukemogenic t(8;21) fusion protein AML1-ETO controls rRNA genes and associates with nucleolar-organizing regions at mitotic chromosomes
J. Cell Sci.,
December 1, 2008;
121(23):
3981 - 3990.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Rubnitz, D. Wichlan, M. Devidas, J. Shuster, S. B. Linda, J. Kurtzberg, B. Bell, S. P. Hunger, A. Chauvenet, C.-H. Pui, et al.
Prospective Analysis of TEL Gene Rearrangements in Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
J. Clin. Oncol.,
May 1, 2008;
26(13):
2186 - 2191.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Accordi, S. Pillozzi, M. C. Dell'Orto, G. Cazzaniga, A. Arcangeli, G. t. Kronnie, and G. Basso
Hepatocyte Growth Factor Receptor c-MET Is Associated with FAS and When Activated Enhances Drug-induced Apoptosis in Pediatric B Acute Lymphoblastic Leukemia with TEL-AML1 Translocation
J. Biol. Chem.,
October 5, 2007;
282(40):
29384 - 29393.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Lierman and J. Cools
ETV6 and PDGFRB: a license to fuse
Haematologica,
February 1, 2007;
92(2):
145 - 147.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. E. Sabaawy, M. Azuma, L. J. Embree, H.-J. Tsai, M. F. Starost, and D. D. Hickstein
TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia
PNAS,
October 10, 2006;
103(41):
15166 - 15171.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. Loh, M. A. Goldwasser, L. B. Silverman, W.-M. Poon, S. Vattikuti, A. Cardoso, D. S. Neuberg, K. M. Shannon, S. E. Sallan, and D. G. Gilliland
Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01
Blood,
June 1, 2006;
107(11):
4508 - 4513.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Cardone, A. Kandilci, C. Carella, J. A. Nilsson, J. A. Brennan, S. Sirma, U. Ozbek, K. Boyd, J. L. Cleveland, and G. C. Grosveld
The Novel ETS Factor TEL2 Cooperates with Myc in B Lymphomagenesis
Mol. Cell. Biol.,
March 15, 2005;
25(6):
2395 - 2405.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Zuna, A. M. Ford, M. Peham, N. Patel, V. Saha, C. Eckert, J. Kochling, R. Panzer-Grumayer, J. Trka, and M. Greaves
TEL Deletion Analysis Supports a Novel View of Relapse in Childhood Acute Lymphoblastic Leukemia
Clin. Cancer Res.,
August 15, 2004;
10(16):
5355 - 5360.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Asakura, H. Uchida, H. Miyachi, H. Kobayashi, Y. Miyakawa, S. D. Nimer, H. Takahashi, Y. Ikeda, and M. Kizaki
TEL/AML1 Overcomes Drug Resistance Through Transcriptional Repression of Multidrug Resistance-1 Gene Expression
Mol. Cancer Res.,
June 1, 2004;
2(6):
339 - 347.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Smith and M. Sigvardsson
The roles of transcription factors in B lymphocyte commitment, development, and transformation
J. Leukoc. Biol.,
June 1, 2004;
75(6):
973 - 981.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Irvin, L. D. Wood, L. Wang, R. Fenrick, C. G. Sansam, G. Packham, M. Kinch, E. Yang, and S. W. Hiebert
TEL, a Putative Tumor Suppressor, Induces Apoptosis and Represses Transcription of Bcl-XL
J. Biol. Chem.,
November 21, 2003;
278(47):
46378 - 46386.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Li, J. Yan, C. J. Matheny, T. Corpora, J. Bravo, A. J. Warren, J. H. Bushweller, and N. A. Speck
Energetic Contribution of Residues in the Runx1 Runt Domain to DNA Binding
J. Biol. Chem.,
August 29, 2003;
278(35):
33088 - 33096.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. L. Carroll, D. Bhojwani, D.-J. Min, E. Raetz, M. Relling, S. Davies, J. R. Downing, C. L. Willman, and J. C. Reed
Pediatric Acute Lymphoblastic Leukemia
Hematology,
January 1, 2003;
2003(1):
102 - 131.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. T. Sandlund, P. L. Harrison, G. Rivera, F. G. Behm, D. Head, J. Boyett, J. E. Rubnitz, A. Gajjar, S. Raimondi, R. Ribeiro, et al.
Persistence of lymphoblasts in bone marrow on day 15 and days 22 to 25 of remission induction predicts a dismal treatment outcome in children with acute lymphoblastic leukemia
Blood,
June 17, 2002;
100(1):
43 - 47.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Mori, S. M. Colman, Z. Xiao, A. M. Ford, L. E. Healy, C. Donaldson, J. M. Hows, C. Navarrete, and M. Greaves
Chromosome translocations and covert leukemic clones are generated during normal fetal development
PNAS,
June 11, 2002;
99(12):
8242 - 8247.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Brown, M. Jawad, S. R. F. Twigg, K. Saracoglu, A. Sauerbrey, A. E. Thomas, R. Eils, J. Harbott, and L. Kearney
A cryptic t(5;11)(q35;p15.5) in 2 children with acute myeloid leukemia with apparently normal karyotypes, identified by a multiplex fluorescence in situ hybridization telomere assay
Blood,
April 1, 2002;
99(7):
2526 - 2531.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. J. Weston, C. M. McConville, J. R. Mann, P. J. Darbyshire, S. Lawson, J. Gordon, P. A. H. Moss, A. Malcolm, R. Taylor, and T. Stankovic
Molecular Analysis of Single Colonies Reveals a Diverse Origin of Initial Clonal Proliferation in B-Precursor Acute Lymphoblastic Leukemia that Can Precede the t(12;21) Translocation
Cancer Res.,
December 1, 2001;
61(23):
8547 - 8553.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. G. Gilliland
The Diverse Role of the ETS Family of Transcription Factors in Cancer: Commentary re: B. Davidson, Ets-1 Messenger RNA Expression Is a Novel Marker of Poor Survival in Ovarian Carcinoma. Clin. Cancer Res., 7: 551-557, 2001.
Clin. Cancer Res.,
March 1, 2001;
7(3):
451 - 453.
[Full Text]
|
|
|
|
|
|
|
M. Eguchi-Ishimae, M. Eguchi, E. Ishii, S. Miyazaki, K. Ueda, N. Kamada, and S. Mizutani
Breakage and fusion of the TEL (ETV6) gene in immature B lymphocytes induced by apoptogenic signals
Blood,
February 1, 2001;
97(3):
737 - 743.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Imai, M. Kurokawa, K. Izutsu, A. Hangaishi, K. Takeuchi, K. Maki, S. Ogawa, S. Chiba, K. Mitani, and H. Hirai
Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesis
Blood,
November 1, 2000;
96(9):
3154 - 3160.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Fenrick, L. Wang, J. Nip, J. M. Amann, R. J. Rooney, J. Walker-Daniels, H. C. Crawford, D. L. Hulboy, M. S. Kinch, L. M. Matrisian, et al.
TEL, a Putative Tumor Suppressor, Modulates Cell Growth and Cell Morphology of Ras-Transformed Cells While Repressing the Transcription of stromelysin-1
Mol. Cell. Biol.,
August 15, 2000;
20(16):
5828 - 5839.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
A. M. Friedmann and H. J. Weinstein
The Role of Prognostic Features in the Treatment of Childhood Acute Lymphoblastic Leukemia
Oncologist,
August 1, 2000;
5(4):
321 - 328.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
N. L. R.-v. Woerden, R. Pieters, A. H. Loonen, I. Hubeek, E. van Drunen, H. B. Beverloo, R. M. Slater, J. Harbott, J. Seyfarth, E. R. van Wering, et al.
TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia
Blood,
August 1, 2000;
96(3):
1094 - 1099.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. K. Strom, J. Nip, J. J. Westendorf, B. Linggi, B. Lutterbach, J. R. Downing, N. Lenny, and S. W. Hiebert
Expression of the AML-1 Oncogene Shortens the G1 Phase of the Cell Cycle
J. Biol. Chem.,
February 4, 2000;
275(5):
3438 - 3445.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T.-L. Gu, T. L. Goetz, B. J. Graves, and N. A. Speck
Auto-Inhibition and Partner Proteins, Core-Binding Factor beta (CBFbeta ) and Ets-1, Modulate DNA Binding by CBFalpha 2 (AML1)
Mol. Cell. Biol.,
January 1, 2000;
20(1):
91 - 103.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
T. R. Golub, D. K. Slonim, P. Tamayo, C. Huard, M. Gaasenbeek, J. P. Mesirov, H. Coller, M. L. Loh, J. R. Downing, M. A. Caligiuri, et al.
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
Science,
October 15, 1999;
286(5439):
531 - 537.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
R. Fenrick, J. M. Amann, B. Lutterbach, L. Wang, J. J. Westendorf, J. R. Downing, and S. W. Hiebert
Both TEL and AML-1 Contribute Repression Domains to the t(12;21) Fusion Protein
Mol. Cell. Biol.,
October 1, 1999;
19(10):
6566 - 6574.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Orfao, G. Schmitz, B. Brando, A. Ruiz-Arguelles, G. Basso, R. Braylan, G. Rothe, F. Lacombe, F. Lanza, S. Papa, et al.
Clinically Useful Information Provided by the Flow Cytometric Immunophenotyping of Hematological Malignancies: Current Status and Future Directions
Clin. Chem.,
October 1, 1999;
45(10):
1708 - 1717.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Wiemels and M. Greaves
Structure and Possible Mechanisms of TEL-AML1 Gene Fusions in Childhood Acute Lymphoblastic Leukemia
Cancer Res.,
August 1, 1999;
59(16):
4075 - 4082.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Wiemels, A. M. Ford, E. R. Van Wering, A. Postma, and M. Greaves
Protracted and Variable Latency of Acute Lymphoblastic Leukemia After TEL-AML1 Gene Fusion In Utero
Blood,
August 1, 1999;
94(3):
1057 - 1062.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. F. Lewis, T. Stacy, W. R. Green, L. Taddesse-Heath, J. W. Hartley, and N. A. Speck
Core-Binding Factor Influences the Disease Specificity of Moloney Murine Leukemia Virus
J. Virol.,
July 1, 1999;
73(7):
5535 - 5547.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
S. P. Thandla, J. E. Ploski, S. Z. Raza-Egilmez, P. P. Chhalliyil, A. W. Block, P. J. de Jong, and P. D. Aplan
ETV6-AML1 Translocation Breakpoints Cluster Near a Purine/Pyrimidine Repeat Region in the ETV6 Gene
Blood,
January 1, 1999;
93(1):
293 - 299.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. Loh, L. B. Silverman, M. L. Young, D. Neuberg, T. R. Golub, S. E. Sallan, and D. G. Gilliland
Incidence of TEL/AML1 Fusion in Children With Relapsed Acute Lymphoblastic Leukemia
Blood,
December 15, 1998;
92(12):
4792 - 4797.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Roulston, R. Espinosa III, G. Nucifora, R. A. Larson, M. M. Le Beau, and J. D. Rowley
CBFA2(AML1) Translocations With Novel Partner Chromosomes in Myeloid Leukemias: Association With Prior Therapy
Blood,
October 15, 1998;
92(8):
2879 - 2885.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. C. Kogan, E. Lagasse, S. Atwater, S.-c. Bae, I. Weissman, Y. Ito, and J. M. Bishop
The PEBP2beta MYH11 fusion created by Inv(16)(p13;q22) in myeloid leukemia impairs neutrophil maturation and contributes to granulocytic dysplasia
PNAS,
September 29, 1998;
95(20):
11863 - 11868.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Pallisgaard, P. Hokland, D. C. Riishoj, B. Pedersen, and P. Jorgensen
Multiplex Reverse Transcription-Polymerase Chain Reaction for Simultaneous Screening of 29 Translocations and Chromosomal Aberrations in Acute Leukemia
Blood,
July 15, 1998;
92(2):
574 - 588.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Faderl, H. M. Kantarjian, M. Talpaz, and Z. Estrov
Clinical Significance of Cytogenetic Abnormalities in Adult Acute Lymphoblastic Leukemia
Blood,
June 1, 1998;
91(11):
3995 - 4019.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Okuda, Z. Cai, S. Yang, N. Lenny, C.-j. Lyu, J. M.A. van Deursen, H. Harada, and J. R. Downing
Expression of a Knocked-In AML1-ETO Leukemia Gene Inhibits the Establishment of Normal Definitive Hematopoiesis and Directly Generates Dysplastic Hematopoietic Progenitors
Blood,
May 1, 1998;
91(9):
3134 - 3143.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Ford, C. A. Bennett, C. M. Price, M. C. A. Bruin, E. R. Van Wering, and M. Greaves
Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia
PNAS,
April 14, 1998;
95(8):
4584 - 4588.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Erman, M. Cortes, B. S. Nikolajczyk, N. A. Speck, and R. Sen
ETS-Core Binding Factor: a Common Composite Motif in Antigen Receptor Gene Enhancers
Mol. Cell. Biol.,
March 1, 1998;
18(3):
1322 - 1330.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
K. Seeger, H.-P. Adams, D. Buchwald, B. Beyermann, B. Kremens, C. Niemeyer, J. Ritter, D. Schwabe, D. Harms, M. Schrappe, et al.
TEL-AML1 Fusion Transcript in Relapsed Childhood Acute Lymphoblastic Leukemia
Blood,
March 1, 1998;
91(5):
1716 - 1722.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Wlodarska, R. La Starza, M. Baens, J. Dierlamm, A. Uyttebroeck, D. Selleslag, A. Francine, C. Mecucci, A. Hagemeijer, H. Van den Berghe, et al.
Fluorescence In Situ Hybridization Characterization of New Translocations Involving TEL (ETV6) in a Wide Spectrum of Hematologic Malignancies
Blood,
February 15, 1998;
91(4):
1399 - 1406.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Westendorf, C. M. Yamamoto, N. Lenny, J. R. Downing, M. E. Selsted, and S. W. Hiebert
The t(8;21) Fusion Product, AML-1-ETO, Associates with C/EBP-alpha , Inhibits C/EBP-alpha -Dependent Transcription, and Blocks Granulocytic Differentiation
Mol. Cell. Biol.,
January 1, 1998;
18(1):
322 - 333.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
Y. Sato, S. K. Bohlander, H. Kobayashi, S. Reshmi, Y. Suto, E. M. Davis, R. Espinosa III, R. Hoopes, K. T. Montgomery, R. S. Kucherlapati, et al.
Heterogeneity in the Breakpoints in Balanced Rearrangements Involving Band 12p13 in Hematologic Malignancies Identified by Fluorescence In Situ Hybridization: TEL (ETV6 ) Is Involved in Only One Half
Blood,
December 15, 1997;
90(12):
4886 - 4893.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Harbott, S. Viehmann, A. Borkhardt, G. Henze, and F. Lampert
Incidence of TEL/AML1 Fusion Gene Analyzed Consecutively in Children With Acute Lymphoblastic Leukemia in Relapse
Blood,
December 15, 1997;
90(12):
4933 - 4937.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Rubnitz and C.-H. Pui
Childhood Acute Lymphoblastic Leukemia
Oncologist,
December 1, 1997;
2(6):
374 - 380.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.C. Raimondi, S.A. Shurtleff, J.R. Downing, J. Rubnitz, S. Mathew, M. Hancock, C-H. Pui, G.K. Rivera, G.C. Grosveld, and F.G. Behm
12p Abnormalities and the TEL Gene (ETV6) in Childhood Acute Lymphoblastic Leukemia
Blood,
December 1, 1997;
90(11):
4559 - 4566.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Lacronique, A. Boureux, V. Della Valle, H. Poirel, C. T. Quang, M. Mauchauffé, C. Berthou, M. Lessard, R. Berger, J. Ghysdael, et al.
A TEL-JAK2 Fusion Protein with Constitutive Kinase Activity in Human Leukemia
Science,
November 14, 1997;
278(5341):
1309 - 1312.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
C. D. Jennings and K. A. Foon
Recent Advances in Flow Cytometry: Application to the Diagnosis of Hematologic Malignancy
Blood,
October 15, 1997;
90(8):
2863 - 2892.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Borkhardt, G. Cazzaniga, S. Viehmann, M. G. Valsecchi, W. D. Ludwig, L. Burci, S. Mangioni, M. Schrappe, H. Riehm, F. Lampert, et al.
Incidence and Clinical Relevance of TEL/AML1 Fusion Genes in Children With Acute Lymphoblastic Leukemia Enrolled in the German and Italian Multicenter Therapy Trials
Blood,
July 15, 1997;
90(2):
571 - 577.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Rubnitz and W. M. Crist
Molecular Genetics of Childhood Cancer: Implications for Pathogenesis, Diagnosis, and Treatment
Pediatrics,
July 1, 1997;
100(1):
101 - 108.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Zeng, A. J. van Wijnen, J. L. Stein, S. Meyers, W. Sun, L. Shopland, J. B. Lawrence, S. Penman, J. B. Lian, G. S. Stein, et al.
Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors
PNAS,
June 24, 1997;
94(13):
6746 - 6751.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Fears, M. Gavin, D.-E. Zhang, C. Hetherington, Y. Ben-David, J. D. Rowley, and G. Nucifora
Functional characterization of ETV6 and ETV6/CBFA2 in the regulation of the MCSFR proximal promoter
PNAS,
March 4, 1997;
94(5):
1949 - 1954.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Wlodarska, A. Aventin, J. Ingles-Esteve, D. Falzetti, A. Criel, J.-J. Cassiman, C. Mecucci, H. Van den Berghe, and P. Marynen
A New Subtype of Pre-B Acute Lymphoblastic Leukemia With t(5; 12)(q31q33; p12), Molecularly and Cytogenetically Distinct From t(5; 12) in Chronic Myelomonocytic Leukemia
Blood,
March 1, 1997;
89(5):
1716 - 1722.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Rubnitz, J. J. Shuster, V. J. Land, M. P. Link, D. J. Pullen, B. M. Camitta, C.-H. Pui, J. R. Downing, and F. G. Behm
Case-Control Study Suggests a Favorable Impact of TEL Rearrangement in Patients With B-Lineage Acute Lymphoblastic Leukemia Treated With Antimetabolite-Based Therapy: A Pediatric Oncology Group Study
Blood,
February 15, 1997;
89(4):
1143 - 1146.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M Baens, P Peeters, C Guo, J Aerssens, and P Marynen
Genomic organization of TEL: the human ETS-variant gene 6.
Genome Res.,
May 1, 1996;
6(5):
404 - 413.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. M. Cuenco, G. Nucifora, and R. Ren
Human AML1/MDS1/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice: A model for human AML
PNAS,
February 15, 2000;
97(4):
1760 - 1765.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Salomon-Nguyen, V. Della-Valle, M. Mauchauffe, M. Busson-Le Coniat, J. Ghysdael, R. Berger, and O. A. Bernard
The t(1;12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion
PNAS,
June 6, 2000;
97(12):
6757 - 6762.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
